Dr. Redman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Dept of Medicine
Washington, DC 20007Phone+1 202-444-8168Fax+1 877-303-1460
Education & Training
National Institutes of Health Clinical CenterFellowship, Medical Oncology, 2014 - 2016
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2013 - 2016
New York Medical CollegeClass of 2013
Certifications & Licensure
MD State Medical License 2016 - 2025
DC State Medical License 2014 - 2024
VA State Medical License 2013 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 3 citationsSpotlight on atezolizumab and its potential as an oncology agent.Jason M. Redman, Ravi A. Madan
Expert Review of Anticancer Therapy. 2018-06-07 - 28 citationsPhase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC).Marijo Bilusic, Sheri McMahon, Ravi A. Madan, Fatima Karzai, Yo-Ting Tsai
Journal for Immunotherapy of Cancer. 2021-03-01 - 34 citationsA Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced CancerMargaret E. Gatti-Mays, Jason M. Redman, Renee N. Donahue, Claudia Palena, Ravi A. Madan
The Oncologist. 2020-06-01
Press Mentions
NantKwest : Key Opinion Leader EventDecember 2nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
